A2A Pharmaceuticals, Inc. - Mar 31, 2023 Form 4/A - Amendment Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Stock symbol
BMEA
Transactions as of
Mar 31, 2023
Transactions value $
-$6,250,000
Form type
4/A - Amendment
Date filed
4/6/2023, 07:31 PM
Date Of Original Report
Mar 31, 2023
Previous filing
Aug 19, 2022
Next filing
Apr 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale -$6.25M -200K -4.65% $31.25 4.1M Mar 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64. Additional details of the individual transactions are available upon request.